Literature DB >> 3876286

Brucella fractions behave as nonspecific mitogens and polyclonal B-cell activators for human lymphocytes.

J P Vendrell, H Rabesandratana, M F Huguet, A Cannat, A Serre.   

Abstract

Two lipid-A-free fractions which were extracted from Brucella melitensis and were designated PI and SF stimulated human unsensitized mononuclear cells to proliferate and to secrete immunoglobulins. Both of these effects were observed in cultures of peripheral blood, tonsils, and cord blood lymphocytes. Neither B cells nor T cells alone proliferated in the presence of these fractions, whereas the proliferative response of T cells plus B cells was largely independent of accessory cells. Polyclonal activation was estimated by counting the cells which secreted immunoglobulins of different isotypes into culture supernatants. This phenomenon was strongly T dependent.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3876286      PMCID: PMC262173          DOI: 10.1128/iai.50.1.310-316.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Monocyte-mediated suppression of human B lymphocyte differentiation in vitro.

Authors:  W Knapp; G Baumgartner
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

2.  Human B cell differentiation. I. Immunoglobulin synthesis induced by Nocardia mitogen.

Authors:  R Ciorbaru; J Brochier
Journal:  Eur J Immunol       Date:  1978-02       Impact factor: 5.532

3.  Assay of immunoglobulins in supernatants of lymphoid cell lines by conventional laser nephelometry.

Authors:  G Virella; J Muñoz; J E Robinson; J M Goust
Journal:  Z Immunitatsforsch Immunobiol       Date:  1979-03

4.  The T cell dependence of B cell differentiation induced by pokeweed mitogen.

Authors:  R G Keightley; M D Cooper; A R Lawton
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

5.  A plaque assay for all cells secreting Ig of a given type or class.

Authors:  E Gronowicz; A Coutinho; F Melchers
Journal:  Eur J Immunol       Date:  1976-08       Impact factor: 5.532

6.  A human T-independent B lymphocyte mitogen extracted from Nocardia opaca.

Authors:  J Brochier; C Bona; R Ciorbaru; J P Revillard; L Chedid
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

7.  Immunization by an insoluble fraction extracted from Brucella melitensis: immunological and chemical characterization of the active substances.

Authors:  A Lopez-Merino; J Asselineau; A Serre; J Roux; S Bascoul; C Lacave
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

8.  Stimulation of mitogenic responses in human peripheral blood lymphocytes by lipopolysaccharide: serum and T helper cell requirements.

Authors:  R A Miller; S Gartner; H S Kaplan
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

9.  Stimulating activity of Brucella fractions in a human lymphocyte transformation test. Correlation with humoral and cellular immunity.

Authors:  S Bascoul; M Peraldi; A L Merino; C Lacave; A Cannat; A Serre
Journal:  Immunology       Date:  1976-11       Impact factor: 7.397

10.  Mitogenic analysis of murine B-cell heterogeneity.

Authors:  C Bona; A Yano; A Dimitriu; R G Miller
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

View more
  3 in total

1.  Protective effect of a T-cell-dependent immunosuppressive, B-cell-mitogenic protein (F3'EP-Si, or P90) produced by Streptococcus intermedius.

Authors:  M Lima; A Bandeira; D Portnoi; A Ribeiro; M A Chaves
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

2.  Antigens of Brucella abortus S19 immunodominant for bovine lymphocytes as identified by one- and two-dimensional cellular immunoblotting.

Authors:  B M Brooks-Worrell; G A Splitter
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

3.  Strong mitogenic effect for murine B lymphocytes of an immunosuppressor substance released by Streptococcus intermedius.

Authors:  M P Arala-Chaves; A S Ribeiro; M M Santarém; A Coutinho
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.